C2R Global Manufacturing, Inc. offers solutions for drug diversion prevention in healthcare which has reached epidemic proportions in the United States. Diversion of controlled substances in healthcare systems puts organizations at risk of significant liability and leads to serious patient safety issues such as inaccurate documentation of care, inadequate pain relief and exposure to infectious disease. Maintaining a drug diversion detection and prevention policy is critical in hospitals and healthcare facilities to combat the epidemic of addiction in the U.S.
According to a study by the National Institute for Drug Abuse released in January of 2019, more than 130 people die each day in the U.S. due to an opioid overdose. The Centers for Disease Control and Prevention estimates a total economic burden of drug addiction in the U.S. at $78.5 billion annually which includes costs of addiction treatment, healthcare, lost productivity and criminal justice involvement. These alarming statistics make maintaining a closely regulated drug diversion prevention policy a top priority to healthcare facilities.
Components of the Drug Diversion Prevention Program
Maintaining a proper “Chain of Custody” of controlled substances is critical for drug diversion prevention and detection in healthcare facilities. A chain of custody refers to a documented trail with either paper witness logs or electronic witness log systems which track the custody, control, transfer and disposition of drugs maintained in hospitals and healthcare settings. Ideally, prescriptions should be tracked from “cradle to grave” with clear documentation of where the pharmaceutical is in the chain of custody.
Most hospitals typically use an electronic system such as Omnicell or BD Pyxis™ PARx™ with barcode scanning technology which requires input into an electronic form of a witness log. C2R Global Manufacturing, Inc. offers a reference Witness Log Form for download which provides a DEA compliant disposal method of controlled substance with witness destruction.
Neutralizing pharmaceutical waste with a DEA and EPA complaint drug disposal system such as with Rx Destroyer™ products provides hospital drug diversion prevention efforts with an easy to use on-site solution which begins neutralizing on contact deeming them irretrievable and not available for misuse. According to the most recent DEA ruling in the Disposal Act, a supplement to the Controlled Substance Act, DEA registrants which includes hospitals must not dispose of controlled substances in collection receptacles, they must be destroyed. See this supplement to the 2014 ruling with additional information for healthcare practitioners.
Drug Diversion Prevention in Healthcare Solutions
C2R Global Manufacturing, Inc. provides proven solutions with high quality products and services, assisting customers with compliant drug diversion prevention strategies. We provide free compliance consultation to qualified customers as well as free samples, education, on-site training and phone support. Our customers have come to trust and rely upon our industry insights, education based philosophy and best practices for quick and effective drug disposal compliance requirements.
Our products are convenient and easy to use with no need to add water and no batteries required. We offer an All-Purpose product list in various sizes to accommodate any healthcare setting which neutralizes pills, capsules, tables, lozenges, liquids, suppositories, transdermal patches and fentanyl lollipops. Our product list for liquid pharmaceuticals including syringe injectables also offers various sizes for the most convenient and economical drug disposal solution especially effective in surgical environments.
C2R Global Manufacturing, Inc. offers quick and seamless facility implementation for DEA and EPA compliance. We are committed to saving water, saving lives…one prescription at a time with compliance made easy. Learn more about our proven solutions on drug diversion prevention in healthcare.